TOMSK, RUSSIA / RankWire.AI / – Russian scientists have conducted tests on a bioactive coating aimed at improving the interaction between titanium orthopedic implants and bone tissue. This material incorporates calcium phosphate derived from hydroxyapatite and contains nitrogen compounds linked to nitric oxide formation. In laboratory experiments, human mesenchymal stem cells demonstrated significantly higher survival rates on coated surfaces compared to uncoated titanium. The researchers analyzed the coating’s structure, chemistry, mechanical characteristics, and biological response. Their peer-reviewed results were published in Applied Surface Science in 2026.
At Tomsk Polytechnic University, scientists produced the experimental coatings by reactive magnetron sputtering of a hydroxyapatite target within a vacuum chamber. During deposition, they adjusted the nitrogen and argon gas ratios to observe how each mixture influenced the final surface. The study tested five different conditions, from pure nitrogen to pure argon. They then measured coating thickness, surface morphology, hardness, wettability, and chemical composition. Additionally, laboratory tests assessed how living human cells responded to the modified titanium substrates.
The results indicated that the argon content influenced several physical properties of the coatings. Surfaces created with pure argon were denser and harder than those produced with pure nitrogen. Coating thickness increased as the argon proportion rose. Chemical analysis revealed nitrogen-carbon and nitrogen-oxygen bonds on the modified surfaces. The team then compared the growth of human mesenchymal stem cells on coated titanium with cells on uncoated titanium. The biological evaluation focused on cell viability and markers associated with bone-cell development.
Coating experiments demonstrate improved cell viability
According to the research, cell experiments showed significantly higher survival rates on coated surfaces than on uncoated titanium. After seven days, coatings with increased nitrogen content also suppressed activity in certain genes linked to early bone-cell differentiation. Despite this, the cells maintained their ability to form bone tissue. The study conducted these assessments under controlled laboratory conditions using human mesenchymal stem cells and did not involve testing the coating in patients or evaluating clinical implant performance.
The biomedical evaluation was carried out by researchers from Immanuel Kant Baltic Federal University and Siberian State Medical University, with additional participation from Saint Petersburg State University. The project was supported by Russia’s state science program. The scientists aimed to identify gas mixtures capable of producing coatings with advantageous physical, chemical, and biological properties. Hydroxyapatite is already used in implant coatings because its calcium phosphate composition closely resembles the mineral component of human bone.
The research remains in laboratory testing phase
The team has outlined future testing plans beyond the initial seven-day cell study. They plan to evaluate stem cells over periods of 10 to 28 days, examine the dissolution rate of the coatings, and measure nitric oxide release into surrounding tissue in living organisms. These follow-up studies were not included in the current published laboratory results. Presently, the focus is on coated titanium substrates, their material properties, and in vitro cellular responses, rather than clinical outcomes in orthopedic patients.
The findings offer comprehensive laboratory data on how the nitrogen and argon gas ratios influence calcium phosphate coatings applied to titanium surfaces. The study documented variations in thickness, density, hardness, chemical bonding, and cellular response across the different gas mixtures. It also confirmed that coated samples supported higher stem-cell survival compared to bare titanium under experimental conditions. However, the research remains preclinical, and these experiments do not establish safety or efficacy in human patients. Additional biological testing will be necessary to explore properties not addressed in this initial study.